Back
Nicolet Bankshares 10K Form
Buy
70
NIC
Nicolet Bankshares
Last Price:
113.46
Seasonality Move:
6.62%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-07 | 10Q | NIC/Nicolet Bankshares Quarterly |
2023-08-04 | 10Q | NIC/Nicolet Bankshares Quarterly |
2023-05-02 | 10Q | NIC/Nicolet Bankshares Quarterly |
2022-11-01 | 10Q | NIC/Nicolet Bankshares Quarterly |
2022-08-08 | 10Q | NIC/Nicolet Bankshares Quarterly |
2022-04-29 | 10Q | NIC/Nicolet Bankshares Quarterly |
Receive NIC News And Ratings
See the #1 stock for the next 7 days that we like better than NIC
NIC Financial Statistics
Sales & Book Value
Annual Sales: | $277.85M |
---|---|
Cash Flow: | $34.72M |
Price / Cash Flow: | 13.86 |
Annual Sales: | $76.09 |
Price / Book: | 1.49 |
Profitability
EPS (TTM): | 7.86000 |
---|---|
Net Income (TTM): | $120.24M |
Gross Margin: | $0 |
Return on Equity: | 11.31% |
Return on Assets: | 1.41% |
Nicolet Bankshares Earnings Forecast
Key Nicolet Bankshares Financial Ratios
- The Gross Profit Margin over the past 9 years for NIC is 0.00%.
- The Selling, General & Administrative Expenses for NIC have been equal to 39.91% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of NIC is 22.14% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 12 years.
Nicolet Bankshares Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Banks |
Sector: | Financials |
Current Symbol: | NIC |
Website: | nicoletbank.com |
Debt
Debt-to-Equity Ratio: | 0.14 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 27.51 |
---|---|
Forward P/E Ratio: | 14.26 |
NIC Technical Analysis vs Fundamental Analysis
Buy
70
Nicolet Bankshares (NIC)
is a Buy
Is Nicolet Bankshares a Buy or a Sell?
-
Nicolet Bankshares stock is rated a Buy
The current Nicolet Bankshares [NIC] share price is $112.23. The Score for NIC is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.